Mass Spectrometry Market by Product (Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software & Services), Sample (LC-MS, GC-MS), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecasts to 2030
The global mass spectrometry market is estimated to reach USD 9.62 billion by 2030 from USD 6.33 billion in 2024, at a CAGR of 7.2% during the forecast period.
The market's growth can be attributed to mass spectrometers' applications in environmental sample testing of analytes like PFAS and microplastics in environmental testing which are expected to increase. The pharmaceutical industry's allocation of larger budgets for research and development and government regulation on drug safety will increase demand for mass spectrometers. Increasing investments in energy exploration and climate studies will stimulate demand for mass spectrometers. Also, the sensitive qualitative and quantitative mandates for food and beverage testing are expected to increase the demand in the mass spectrometry market.
“In terms of product, the instruments segment accounted the largest share in the global mass spectrometry market for the year 2023”
Based on the product, the mass spectrometry is segmented into instruments and software & services. The hybrid mass spectrometry segment accounts for the largest share of the mass spectrometry market. Hybrid mass spectrometers exhibit, rapid and high-resolution testing abilities with more accurate and precise results. Hybrid mass spectrometers incorporate at least two component mass analyzers of different types arranged in sequence from the ion source to the ion detector. This greatly increases their sensitivity, accuracy, resolution, and efficiency, which drives their adoption on a significant level when compared to single mass analyzers. Moreover, analyses performed with hybrid mass spectrometers yield large volumes of complex data at high speed and resolution and result in accurate and better analysis, companies tend to provide software to manage and analyze such data sets.
The growth of the mass spectrometry instruments market will primarily be driven by the procedural benefits offered by mass spectrometers as they can be used for different applications, such as classifying unknown substances by molecular weight measurement, measuring known compounds, and determining the structure and chemical properties of molecules.
'In terms of sample preparation technique, the LC-MS segment accounted for the largest share during the forecast period”
LC-MS is one of the most commonly used analytical techniques in various sectors for the quantitation and identification of unknowns from a variety of complex samples. The use of LC-MS has expanded over the years as it offers both selectivity and specificity in analysis. With advances in mass spectrometry, the sensitivity and accuracy of this technique have further increased, allowing for the detection and identification of low-level analytes in complex sample matrices. Liquid chromatography (LC) is a technique widely used to separate compounds from a sample before analysis and is frequently coupled to mass spectrometry.
The advent of new applications of LC-MS for testing emerging contaminants from third-party testing service providers and labs has increased in the last three years. All these conditions have helped LC-MS to acquire a major share in the mass spectrometry market.
“In terms of applications, the OMICS research segment registered the fastest growth during the forecast period”
Due to the high sensitivity and selection of mass spectrometry, it has also found applications in genomics research to characterize single nucleotide polymorphisms and short tandem repeats. In metabolomics, mass spectrometry has also shown promising results in diabetes studies, as it helps in distinguishing specific changes in the serum profile of metabolites extracted from healthy people and those with type 2 diabetes mellitus. It is also effective in newborn screening, leading to a portfolio of multiplexing assays for congenital metabolic errors.
The OMICS research segment is expected to witness significant growth during the forecast period. The biopharmaceutical and biotechnology industries have facilitated the advancement of diagnostics & biomarker identification applications in the R&D sector, leading to its significant growth and dominance in the industry in the upcoming years.
“In terms of end users, the pharmaceutical companies acquired the largest share of the global mass spectrometry market.”
Several regulations for pharmaceutical manufacturing sites have been implemented that confines the metal residues and endotoxins in pharmaceutical products to certain limits, this is quantified on parameters for active pharmaceutical ingredients (API) in production volume. These constrictions have prompted pharmaceutical companies to procure and utilize mass spectrometers in their QC departments. Also, the anticipated revenue growth of this segment during the forecast period is attributed to the rapid expansion of the pharmaceutical industry worldwide and the technological advancements in the pharmaceutical sectors.
All these factors have favored the adoption mass spectrometry technique more to deliver quality end products.
“The market in the North America region is expected to hold significant market share for mass spectrometry in 2023.”
The mass spectrometry market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for mass spectrometry in 2023. The growth of the mass spectrometry market in this region can be attributed to the increasing investments in pharmaceutical R&D and government funding for R&D activities.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
The research report examines the mass spectrometry market by product, sample preparation technique, application, end-users, and geography. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions along with micro-market analysis.
Rationale to Buy the Report
The research report will help smaller and newer businesses as well as established ones understand the state of the market, which will help them increase their market share. Businesses that purchase the study may choose to employ one or more of the tactics listed below to increase their market presence.
This report provides insightful data on the following pointers:
The market's growth can be attributed to mass spectrometers' applications in environmental sample testing of analytes like PFAS and microplastics in environmental testing which are expected to increase. The pharmaceutical industry's allocation of larger budgets for research and development and government regulation on drug safety will increase demand for mass spectrometers. Increasing investments in energy exploration and climate studies will stimulate demand for mass spectrometers. Also, the sensitive qualitative and quantitative mandates for food and beverage testing are expected to increase the demand in the mass spectrometry market.
“In terms of product, the instruments segment accounted the largest share in the global mass spectrometry market for the year 2023”
Based on the product, the mass spectrometry is segmented into instruments and software & services. The hybrid mass spectrometry segment accounts for the largest share of the mass spectrometry market. Hybrid mass spectrometers exhibit, rapid and high-resolution testing abilities with more accurate and precise results. Hybrid mass spectrometers incorporate at least two component mass analyzers of different types arranged in sequence from the ion source to the ion detector. This greatly increases their sensitivity, accuracy, resolution, and efficiency, which drives their adoption on a significant level when compared to single mass analyzers. Moreover, analyses performed with hybrid mass spectrometers yield large volumes of complex data at high speed and resolution and result in accurate and better analysis, companies tend to provide software to manage and analyze such data sets.
The growth of the mass spectrometry instruments market will primarily be driven by the procedural benefits offered by mass spectrometers as they can be used for different applications, such as classifying unknown substances by molecular weight measurement, measuring known compounds, and determining the structure and chemical properties of molecules.
'In terms of sample preparation technique, the LC-MS segment accounted for the largest share during the forecast period”
LC-MS is one of the most commonly used analytical techniques in various sectors for the quantitation and identification of unknowns from a variety of complex samples. The use of LC-MS has expanded over the years as it offers both selectivity and specificity in analysis. With advances in mass spectrometry, the sensitivity and accuracy of this technique have further increased, allowing for the detection and identification of low-level analytes in complex sample matrices. Liquid chromatography (LC) is a technique widely used to separate compounds from a sample before analysis and is frequently coupled to mass spectrometry.
The advent of new applications of LC-MS for testing emerging contaminants from third-party testing service providers and labs has increased in the last three years. All these conditions have helped LC-MS to acquire a major share in the mass spectrometry market.
“In terms of applications, the OMICS research segment registered the fastest growth during the forecast period”
Due to the high sensitivity and selection of mass spectrometry, it has also found applications in genomics research to characterize single nucleotide polymorphisms and short tandem repeats. In metabolomics, mass spectrometry has also shown promising results in diabetes studies, as it helps in distinguishing specific changes in the serum profile of metabolites extracted from healthy people and those with type 2 diabetes mellitus. It is also effective in newborn screening, leading to a portfolio of multiplexing assays for congenital metabolic errors.
The OMICS research segment is expected to witness significant growth during the forecast period. The biopharmaceutical and biotechnology industries have facilitated the advancement of diagnostics & biomarker identification applications in the R&D sector, leading to its significant growth and dominance in the industry in the upcoming years.
“In terms of end users, the pharmaceutical companies acquired the largest share of the global mass spectrometry market.”
Several regulations for pharmaceutical manufacturing sites have been implemented that confines the metal residues and endotoxins in pharmaceutical products to certain limits, this is quantified on parameters for active pharmaceutical ingredients (API) in production volume. These constrictions have prompted pharmaceutical companies to procure and utilize mass spectrometers in their QC departments. Also, the anticipated revenue growth of this segment during the forecast period is attributed to the rapid expansion of the pharmaceutical industry worldwide and the technological advancements in the pharmaceutical sectors.
All these factors have favored the adoption mass spectrometry technique more to deliver quality end products.
“The market in the North America region is expected to hold significant market share for mass spectrometry in 2023.”
The mass spectrometry market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for mass spectrometry in 2023. The growth of the mass spectrometry market in this region can be attributed to the increasing investments in pharmaceutical R&D and government funding for R&D activities.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 -35%, Tier 2– 45%, and Tier 3– 20%
- By Designation: C-level- 35%, Directors–25%, and Others–40%
- By Region: North America–40%, Europe–30%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Research Coverage
The research report examines the mass spectrometry market by product, sample preparation technique, application, end-users, and geography. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions along with micro-market analysis.
Rationale to Buy the Report
The research report will help smaller and newer businesses as well as established ones understand the state of the market, which will help them increase their market share. Businesses that purchase the study may choose to employ one or more of the tactics listed below to increase their market presence.
This report provides insightful data on the following pointers:
- Market Penetration: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market.
- Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market.
- Market Development: Insightful data on profitable developing areas.
- Market Diversification: Details about recent developments and advancements in the mass spectrometry market.
- Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1.1 RESEARCH DATA
2.1.2 SECONDARY DATA
2.1.2.1 Indicative list of secondary sources
2.1.2.2 Key data from secondary sources
2.1.3 PRIMARY DATA
2.1.3.1 Primary sources
2.1.3.2 Key data from primary sources
2.1.3.3 Key industry insights
2.1.3.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MAPPING MARKET ESTIMATION
2.3 GROWTH FORECASTING MODEL
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MASS SPECTROSCOPY MARKET OVERVIEW
4.2 MASS SPECTROSCOPY MARKET SHARE, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
4.3 MASS SPECTROSCOPY MARKET, BY INLET TYPE, 2024 VS. 2030 (USD MILLION)
4.4 MASS SPECTROSCOPY MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
4.5 MASS SPECTROSCOPY MARKET, BY REGION, 2023
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing regulatory emphasis and privatization of environmental testing services
5.2.1.2 Growing application of mass spectrometry in clinical and forensic settings
5.2.1.3 Rising focus on drug safety
5.2.1.4 Increasing investments in pharmaceutical research & development
5.2.2 RESTRAINTS
5.2.2.1 Capital-intensive investments for high-end equipment
5.2.2.2 Time-consuming sample preparation steps
5.2.3 OPPORTUNITIES
5.2.3.1 Development of novel mass sensors and nanopore ion sources
5.2.3.2 Growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Inadequate infrastructure and shortage of skilled professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 VALUE CHAIN ANALYSIS
5.5.1 R&D
5.5.2 RAW MATERIAL PROCUREMENT AND PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.5.4 AFTERMARKET SERVICES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.6.4 SALES AND DISTRIBUTION
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Quadrupole mass analyzers
5.9.1.2 Time-of-flight mass analyzers
5.9.1.3 Ion trap mass analyzers
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 LC-MS
5.9.2.2 GC-MS
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Mass spectrometry imaging
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT SCENARIO FOR HS CODE 9027
5.11.2 EXPORT SCENARIO FOR HS CODE 9027
5.12 KEY CONFERENCES AND EVENTS, 2025–2026
5.13 CASE STUDY ANALYSIS
5.13.1 USE OF MASS SPECTROMETRY INSTRUMENTS FOR CLINICAL DIAGNOSTICS
5.14 REGULATORY LANDSCAPE
5.14.1 REGULATORY ANALYSIS
5.14.1.1 North America
5.14.1.2 Europe
5.14.1.3 Asia Pacific
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15 PORTER’S FIVE FORCE ANALYSIS
5.15.1 BARGAINING POWER OF SUPPLIERS
5.15.2 BARGAINING POWER OF BUYERS
5.15.3 THREAT OF NEW ENTRANTS
5.15.4 THREAT OF SUBSTITUTES
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 KEY BUYING CRITERIA
5.17 UNMET NEEDS
5.18 IMPACT OF AI/GEN AI ON MASS SPECTROMETRY MARKET
5.18.1 INTRODUCTION
5.18.2 MARKET POTENTIAL OF MASS SPECTROMETRY
5.18.3 AI USE CASES
5.18.4 KEY COMPANIES IMPLEMENTING AI
5.18.5 FUTURE OF AI/GEN AI IN MASS SPECTROMETRY ECOSYSTEM
6 MASS SPECTROMETRY MARKET, BY INLET TYPE
6.1 INTRODUCTION
6.2 LC-MS
6.2.1 REGULATORY SHIFT TO BOOST MARKET
6.3 GC-MS
6.3.1 INCREASING FOCUS ON ANALYZING ENVIRONMENTAL CONTAMINANTS TO SUSTAIN GROWTH
6.4 ICP-MS
6.4.1 NEED FOR SIMPLE SAMPLE PREPARATION AND HIGH THROUGHPUT TO BOLSTER GROWTH
6.5 OTHER INLET TYPES
7 MASS SPECTROMETRY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 INSTRUMENTS
7.2.1 HYBRID MASS SPECTROMETRY INSTRUMENTS
7.2.1.1 Triple quadrupole MS
7.2.1.1.1 Rising use of advanced analytical instruments to bolster growth
7.2.1.2 Quadrupole-time of flight MS
7.2.1.2.1 Increasing use of Q-TOF mass spectrometry for metabolomics research and food authenticity testing to facilitate growth
7.2.1.3 Fourier transform MS
7.2.1.3.1 Need for high resolution and mass measurement accuracy to increase growth
7.2.2 SINGLE MASS SPECTROMETRY INSTRUMENTS
7.2.2.1 Quadrupole MS
7.2.2.1.1 Growing applications of quadrupole mass spectrometers in biotechnology and pharmaceutical industries to drive market
7.2.2.2 Time-of-flight MS
7.2.2.2.1 Increasing focus on biological analysis applications to expedite growth
7.2.2.3 Ion trap MS
7.2.2.3.1 Need for enhanced capabilities in research areas to contribute to growth
7.2.3 OTHER MASS SPECTROMETRY INSTRUMENTS
7.3 SOFTWARE & SERVICES
7.3.1 ONGOING AUTOMATION AND DIGITALIZATION OF LABORATORY PROCESSES TO AUGMENT GROWTH
8 MASS SPECTROMETRY MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 OMICS RESEARCH
8.2.1 GROWING ADVANCEMENTS IN BIOLOGICAL RESEARCH IN PROTEOMICS AND GENOMICS TO PROPEL MARKET
8.3 DRUG DISCOVERY
8.3.1 NEED FOR HIGHER EFFICACY AND PRODUCT QUALITY TO ENCOURAGE GROWTH
8.4 ENVIRONMENTAL TESTING
8.4.1 GROWING WATER POLLUTION AND ENFORCEMENT OF ENVIRONMENTAL PROTECTION TO FUEL MARKET
8.5 FOOD TESTING
8.5.1 INCREASING IMPORTANCE OF SAFETY STANDARDS TO AMPLIFY GROWTH
8.6 PHARMA/BIOPHARMA MANUFACTURING
8.6.1 RISING USE OF MASS SPECTROMETRY IN PESTICIDE RESIDUE ANALYSIS, PROTEIN IDENTIFICATION, AND CARBON DATING TO AID GROWTH
8.7 CLINICAL DIAGNOSTICS
8.7.1 GROWING USE OF MASS SPECTROMETRY IN DRUG MONITORING, TOXICOLOGY, AND ENDOCRINOLOGY TO DRIVE MARKET
8.8 APPLIED SCIENCES
8.8.1 NEED FOR QUALITY CONTROL IN SEMICONDUCTOR INDUSTRY TO SUPPORT GROWTH
8.9 OTHER APPLICATIONS
9 MASS SPECTROMETRY MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL COMPANIES
9.2.1 BOOMING CLINICAL TRIALS AND DRUG DISCOVERY TO STIMULATE GROWTH
9.3 BIOTECHNOLOGY COMPANIES
9.3.1 GROWING ADOPTION OF MASS SPECTROMETRY IN AGRICULTURE, PROTEOMICS, GENOMICS, AND FOOD TECHNOLOGY TO DRIVE MARKET
9.4 RESEARCH LABS & ACADEMIC INSTITUTES
9.4.1 INCREASING MASS SPECTROMETRY APPLICATIONS IN METABOLIC FINGERPRINTING ANALYSIS AND BIOMARKER DISCOVERY TO AID GROWTH
9.5 ENVIRONMENTAL TESTING LABS
9.5.1 INCREASING SOIL AND POLLUTION MONITORING TO SPEED UP GROWTH
9.6 FOOD & BEVERAGE INDUSTRY
9.6.1 GROWING DEMAND FOR HIGH-QUALITY, SAFE, AND NUTRITIOUS PRODUCTS TO FUEL MARKET
9.7 FORENSIC LABS
9.7.1 RISING TECHNOLOGICAL ADVANCEMENTS IN FORENSIC SCIENCE TO SUSTAIN GROWTH
9.8 PETROCHEMICAL INDUSTRY
9.8.1 GROWING OIL DEMAND TO DRIVE MARKET
9.9 OTHER END USERS
10 MASS SPECTROMETRY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Increasing availability of funding research to augment growth
10.2.3 CANADA
10.2.3.1 Growing focus on clean energy technology to propel market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increasing adoption of advanced mass spectrometry in healthcare to expedite growth
10.3.3 UK
10.3.3.1 Rising focus on testing food products to sustain growth
10.3.4 FRANCE
10.3.4.1 Increasing emphasis on molecular-scale data storage to favor growth
10.3.5 ITALY
10.3.5.1 Growing utilization of mass spectrometry among pharmaceutical and biotechnology end-use industries to drive market
10.3.6 SPAIN
10.3.6.1 Growing pharmaceutical exports to boost market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Progressive manufacturing landscape to augment growth
10.4.3 CHINA
10.4.3.1 Increasing investments in scientific R&D to advance growth
10.4.4 INDIA
10.4.4.1 Increasing focus on environmental technology market to boost market
10.4.5 SOUTH KOREA
10.4.5.1 Rising focus on biotechnology to stimulate growth
10.4.6 AUSTRALIA
10.4.6.1 Increasing focus on early disease diagnosis and development of RNA therapies to aid growth
10.4.7 SOUTHEAST ASIA
10.4.7.1 Growing focus on developing and commercializing innovative drugs to fuel market
10.4.8 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Booming biomanufacturing and life sciences industries to encourage growth
10.5.3 MEXICO
10.5.3.1 Expanding local manufacturing capabilities to accelerate growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Favorable government initiatives to contribute to growth
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MASS SPECTROMETRY MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 MARKET RANKING ANALYSIS, 2023
11.6 COMPANY VALUATION AND FINANCIAL METRICS
11.7 BRAND/PRODUCT COMPARISON
11.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.8.1 STARS
11.8.2 EMERGING LEADERS
11.8.3 PERVASIVE PLAYERS
11.8.4 PARTICIPANTS
11.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.8.5.1 Company footprint
11.8.5.2 Region footprint
11.8.5.3 Product footprint
11.8.5.4 Application footprint
11.8.5.5 End-user footprint
11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.9.1 PROGRESSIVE COMPANIES
11.9.2 RESPONSIVE COMPANIES
11.9.3 DYNAMIC COMPANIES
11.9.4 STARTING BLOCKS
11.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
11.9.5.1 Detailed list of key startups/SMEs
11.9.5.2 Competitive benchmarking of key startups/SMEs
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES AND APPROVALS
11.10.2 DEALS
11.10.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 AGILENT TECHNOLOGIES, INC.
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches and approvals
12.1.1.3.2 Deals
12.1.1.3.3 Expansions
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 THERMO FISHER SCIENTIFIC INC.
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 WATERS CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches and approvals
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 DANAHER
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches and approvals
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 BRUKER
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 SHIMADZU CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches and approvals
12.1.6.3.2 Deals
12.1.6.3.3 Expansions
12.1.7 MKS INSTRUMENTS
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 PERKINELMER
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches and approvals
12.1.8.3.2 Deals
12.1.9 JEOL LTD.
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 HITACHI HIGH-TECH CORPORATION
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Other developments
12.1.11 TELEDYNE TECHNOLOGIES INCORPORATED
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 AMETEK.INC.
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 JASCO CORPORATION
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 F. HOFFMANN-LA ROCHE LTD
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches and approvals
12.2 OTHER PLAYERS
12.2.1 ANALYTIK JENA GMBH+CO. KG
12.2.2 HIDEN ANALYTICAL
12.2.3 LECO CORPORATION
12.2.4 RIGAKU HOLDINGS CORPORATION
12.2.5 YOUNGIN CHROMASS
12.2.6 SCION INSTRUMENTS
12.2.7 KORE TECHNOLOGY
12.2.8 PROCESS INSIGHTS, INC.
12.2.9 MASSTECH
12.2.10 ADVION, INC.
12.2.11 SPACETEK TECHNOLOGY AG
12.2.12 ELEMENTAR ANALYSENSYSTEME GMBH
12.2.13 SKYRAY INSTRUMENTS USA, INC.
12.2.14 MICROSAIC
12.2.15 PFEIFFER VACUUM+FAB SOLUTIONS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1.1 RESEARCH DATA
2.1.2 SECONDARY DATA
2.1.2.1 Indicative list of secondary sources
2.1.2.2 Key data from secondary sources
2.1.3 PRIMARY DATA
2.1.3.1 Primary sources
2.1.3.2 Key data from primary sources
2.1.3.3 Key industry insights
2.1.3.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MAPPING MARKET ESTIMATION
2.3 GROWTH FORECASTING MODEL
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MASS SPECTROSCOPY MARKET OVERVIEW
4.2 MASS SPECTROSCOPY MARKET SHARE, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
4.3 MASS SPECTROSCOPY MARKET, BY INLET TYPE, 2024 VS. 2030 (USD MILLION)
4.4 MASS SPECTROSCOPY MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
4.5 MASS SPECTROSCOPY MARKET, BY REGION, 2023
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing regulatory emphasis and privatization of environmental testing services
5.2.1.2 Growing application of mass spectrometry in clinical and forensic settings
5.2.1.3 Rising focus on drug safety
5.2.1.4 Increasing investments in pharmaceutical research & development
5.2.2 RESTRAINTS
5.2.2.1 Capital-intensive investments for high-end equipment
5.2.2.2 Time-consuming sample preparation steps
5.2.3 OPPORTUNITIES
5.2.3.1 Development of novel mass sensors and nanopore ion sources
5.2.3.2 Growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Inadequate infrastructure and shortage of skilled professionals
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 VALUE CHAIN ANALYSIS
5.5.1 R&D
5.5.2 RAW MATERIAL PROCUREMENT AND PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.5.4 AFTERMARKET SERVICES
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.6.4 SALES AND DISTRIBUTION
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Quadrupole mass analyzers
5.9.1.2 Time-of-flight mass analyzers
5.9.1.3 Ion trap mass analyzers
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 LC-MS
5.9.2.2 GC-MS
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Mass spectrometry imaging
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT SCENARIO FOR HS CODE 9027
5.11.2 EXPORT SCENARIO FOR HS CODE 9027
5.12 KEY CONFERENCES AND EVENTS, 2025–2026
5.13 CASE STUDY ANALYSIS
5.13.1 USE OF MASS SPECTROMETRY INSTRUMENTS FOR CLINICAL DIAGNOSTICS
5.14 REGULATORY LANDSCAPE
5.14.1 REGULATORY ANALYSIS
5.14.1.1 North America
5.14.1.2 Europe
5.14.1.3 Asia Pacific
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15 PORTER’S FIVE FORCE ANALYSIS
5.15.1 BARGAINING POWER OF SUPPLIERS
5.15.2 BARGAINING POWER OF BUYERS
5.15.3 THREAT OF NEW ENTRANTS
5.15.4 THREAT OF SUBSTITUTES
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 KEY BUYING CRITERIA
5.17 UNMET NEEDS
5.18 IMPACT OF AI/GEN AI ON MASS SPECTROMETRY MARKET
5.18.1 INTRODUCTION
5.18.2 MARKET POTENTIAL OF MASS SPECTROMETRY
5.18.3 AI USE CASES
5.18.4 KEY COMPANIES IMPLEMENTING AI
5.18.5 FUTURE OF AI/GEN AI IN MASS SPECTROMETRY ECOSYSTEM
6 MASS SPECTROMETRY MARKET, BY INLET TYPE
6.1 INTRODUCTION
6.2 LC-MS
6.2.1 REGULATORY SHIFT TO BOOST MARKET
6.3 GC-MS
6.3.1 INCREASING FOCUS ON ANALYZING ENVIRONMENTAL CONTAMINANTS TO SUSTAIN GROWTH
6.4 ICP-MS
6.4.1 NEED FOR SIMPLE SAMPLE PREPARATION AND HIGH THROUGHPUT TO BOLSTER GROWTH
6.5 OTHER INLET TYPES
7 MASS SPECTROMETRY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 INSTRUMENTS
7.2.1 HYBRID MASS SPECTROMETRY INSTRUMENTS
7.2.1.1 Triple quadrupole MS
7.2.1.1.1 Rising use of advanced analytical instruments to bolster growth
7.2.1.2 Quadrupole-time of flight MS
7.2.1.2.1 Increasing use of Q-TOF mass spectrometry for metabolomics research and food authenticity testing to facilitate growth
7.2.1.3 Fourier transform MS
7.2.1.3.1 Need for high resolution and mass measurement accuracy to increase growth
7.2.2 SINGLE MASS SPECTROMETRY INSTRUMENTS
7.2.2.1 Quadrupole MS
7.2.2.1.1 Growing applications of quadrupole mass spectrometers in biotechnology and pharmaceutical industries to drive market
7.2.2.2 Time-of-flight MS
7.2.2.2.1 Increasing focus on biological analysis applications to expedite growth
7.2.2.3 Ion trap MS
7.2.2.3.1 Need for enhanced capabilities in research areas to contribute to growth
7.2.3 OTHER MASS SPECTROMETRY INSTRUMENTS
7.3 SOFTWARE & SERVICES
7.3.1 ONGOING AUTOMATION AND DIGITALIZATION OF LABORATORY PROCESSES TO AUGMENT GROWTH
8 MASS SPECTROMETRY MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 OMICS RESEARCH
8.2.1 GROWING ADVANCEMENTS IN BIOLOGICAL RESEARCH IN PROTEOMICS AND GENOMICS TO PROPEL MARKET
8.3 DRUG DISCOVERY
8.3.1 NEED FOR HIGHER EFFICACY AND PRODUCT QUALITY TO ENCOURAGE GROWTH
8.4 ENVIRONMENTAL TESTING
8.4.1 GROWING WATER POLLUTION AND ENFORCEMENT OF ENVIRONMENTAL PROTECTION TO FUEL MARKET
8.5 FOOD TESTING
8.5.1 INCREASING IMPORTANCE OF SAFETY STANDARDS TO AMPLIFY GROWTH
8.6 PHARMA/BIOPHARMA MANUFACTURING
8.6.1 RISING USE OF MASS SPECTROMETRY IN PESTICIDE RESIDUE ANALYSIS, PROTEIN IDENTIFICATION, AND CARBON DATING TO AID GROWTH
8.7 CLINICAL DIAGNOSTICS
8.7.1 GROWING USE OF MASS SPECTROMETRY IN DRUG MONITORING, TOXICOLOGY, AND ENDOCRINOLOGY TO DRIVE MARKET
8.8 APPLIED SCIENCES
8.8.1 NEED FOR QUALITY CONTROL IN SEMICONDUCTOR INDUSTRY TO SUPPORT GROWTH
8.9 OTHER APPLICATIONS
9 MASS SPECTROMETRY MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL COMPANIES
9.2.1 BOOMING CLINICAL TRIALS AND DRUG DISCOVERY TO STIMULATE GROWTH
9.3 BIOTECHNOLOGY COMPANIES
9.3.1 GROWING ADOPTION OF MASS SPECTROMETRY IN AGRICULTURE, PROTEOMICS, GENOMICS, AND FOOD TECHNOLOGY TO DRIVE MARKET
9.4 RESEARCH LABS & ACADEMIC INSTITUTES
9.4.1 INCREASING MASS SPECTROMETRY APPLICATIONS IN METABOLIC FINGERPRINTING ANALYSIS AND BIOMARKER DISCOVERY TO AID GROWTH
9.5 ENVIRONMENTAL TESTING LABS
9.5.1 INCREASING SOIL AND POLLUTION MONITORING TO SPEED UP GROWTH
9.6 FOOD & BEVERAGE INDUSTRY
9.6.1 GROWING DEMAND FOR HIGH-QUALITY, SAFE, AND NUTRITIOUS PRODUCTS TO FUEL MARKET
9.7 FORENSIC LABS
9.7.1 RISING TECHNOLOGICAL ADVANCEMENTS IN FORENSIC SCIENCE TO SUSTAIN GROWTH
9.8 PETROCHEMICAL INDUSTRY
9.8.1 GROWING OIL DEMAND TO DRIVE MARKET
9.9 OTHER END USERS
10 MASS SPECTROMETRY MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Increasing availability of funding research to augment growth
10.2.3 CANADA
10.2.3.1 Growing focus on clean energy technology to propel market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Increasing adoption of advanced mass spectrometry in healthcare to expedite growth
10.3.3 UK
10.3.3.1 Rising focus on testing food products to sustain growth
10.3.4 FRANCE
10.3.4.1 Increasing emphasis on molecular-scale data storage to favor growth
10.3.5 ITALY
10.3.5.1 Growing utilization of mass spectrometry among pharmaceutical and biotechnology end-use industries to drive market
10.3.6 SPAIN
10.3.6.1 Growing pharmaceutical exports to boost market
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 JAPAN
10.4.2.1 Progressive manufacturing landscape to augment growth
10.4.3 CHINA
10.4.3.1 Increasing investments in scientific R&D to advance growth
10.4.4 INDIA
10.4.4.1 Increasing focus on environmental technology market to boost market
10.4.5 SOUTH KOREA
10.4.5.1 Rising focus on biotechnology to stimulate growth
10.4.6 AUSTRALIA
10.4.6.1 Increasing focus on early disease diagnosis and development of RNA therapies to aid growth
10.4.7 SOUTHEAST ASIA
10.4.7.1 Growing focus on developing and commercializing innovative drugs to fuel market
10.4.8 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Booming biomanufacturing and life sciences industries to encourage growth
10.5.3 MEXICO
10.5.3.1 Expanding local manufacturing capabilities to accelerate growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Favorable government initiatives to contribute to growth
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MASS SPECTROMETRY MARKET
11.3 REVENUE ANALYSIS, 2019–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 MARKET RANKING ANALYSIS, 2023
11.6 COMPANY VALUATION AND FINANCIAL METRICS
11.7 BRAND/PRODUCT COMPARISON
11.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.8.1 STARS
11.8.2 EMERGING LEADERS
11.8.3 PERVASIVE PLAYERS
11.8.4 PARTICIPANTS
11.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.8.5.1 Company footprint
11.8.5.2 Region footprint
11.8.5.3 Product footprint
11.8.5.4 Application footprint
11.8.5.5 End-user footprint
11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.9.1 PROGRESSIVE COMPANIES
11.9.2 RESPONSIVE COMPANIES
11.9.3 DYNAMIC COMPANIES
11.9.4 STARTING BLOCKS
11.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
11.9.5.1 Detailed list of key startups/SMEs
11.9.5.2 Competitive benchmarking of key startups/SMEs
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES AND APPROVALS
11.10.2 DEALS
11.10.3 EXPANSIONS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 AGILENT TECHNOLOGIES, INC.
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches and approvals
12.1.1.3.2 Deals
12.1.1.3.3 Expansions
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 THERMO FISHER SCIENTIFIC INC.
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches and approvals
12.1.2.3.2 Deals
12.1.2.3.3 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses and competitive threats
12.1.3 WATERS CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches and approvals
12.1.3.3.2 Deals
12.1.3.3.3 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 DANAHER
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Product launches and approvals
12.1.4.3.2 Deals
12.1.4.3.3 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Right to win
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 BRUKER
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches and approvals
12.1.5.3.2 Deals
12.1.5.3.3 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Right to win
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 SHIMADZU CORPORATION
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches and approvals
12.1.6.3.2 Deals
12.1.6.3.3 Expansions
12.1.7 MKS INSTRUMENTS
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 PERKINELMER
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches and approvals
12.1.8.3.2 Deals
12.1.9 JEOL LTD.
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 HITACHI HIGH-TECH CORPORATION
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Other developments
12.1.11 TELEDYNE TECHNOLOGIES INCORPORATED
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 AMETEK.INC.
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 JASCO CORPORATION
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 F. HOFFMANN-LA ROCHE LTD
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.14.3 Recent developments
12.1.14.3.1 Product launches and approvals
12.2 OTHER PLAYERS
12.2.1 ANALYTIK JENA GMBH+CO. KG
12.2.2 HIDEN ANALYTICAL
12.2.3 LECO CORPORATION
12.2.4 RIGAKU HOLDINGS CORPORATION
12.2.5 YOUNGIN CHROMASS
12.2.6 SCION INSTRUMENTS
12.2.7 KORE TECHNOLOGY
12.2.8 PROCESS INSIGHTS, INC.
12.2.9 MASSTECH
12.2.10 ADVION, INC.
12.2.11 SPACETEK TECHNOLOGY AG
12.2.12 ELEMENTAR ANALYSENSYSTEME GMBH
12.2.13 SKYRAY INSTRUMENTS USA, INC.
12.2.14 MICROSAIC
12.2.15 PFEIFFER VACUUM+FAB SOLUTIONS
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
